An introduction to the history of cannabis use as a medicine.

In this video, Dr. David Bearman discusses the immediate challenges facing medicinal cannabis. He covers the earliest known timeline for cannabis in China's first known pharmacopeia, ancient uses of cannabis through the 1930s, and the beginning of the cannabis prohibition era.

In this video, Dr. David Bearman discusses the history of medical cannabis from the 1930s, starting with Harry Anslinger's demonization of cannabis, racism, prohibitionist propaganda through the Marijuana Tax Act, Controlled Substances Act, and the Compassionate Investigational New Drug (IND) Program.

In this video, Dr. Bearman provides an overview of the timeline of specific laws and acts that have impacted cannabis laws in the United States.

In this video, Dr. Bearman discusses the first modern study on the medicinal value of cannabis, Raphael Mechoulam's characterization of the structure of Delta 9 THC, and the implementation of the Federal Compassionate Access Investigational New Drug Program. He also discusses Marinol (Synthetic THC).

In this video, Dr. Bearman discusses cannabis safety from a federal standpoint. The overview of the timeline focuses on multiple international studies on the safety of cannabis as well as the discovery of Nabixamols (Sativex).

Dr. Bearman discusses medical professionals' concerns over states rights and cannabis.

An introduction to the endocannabinoid system.

In this video, Dr. Joseph Morgan discusses a short history of cannabis and mainstream medicine, and the double-blind, placebo-controlled crossover.

In this video, Dr. Morgan compares cannabis to other commonly used drugs.

In this video, Dr. Morgan discusses ECS key concepts, endocannabinoids, their receptors, precursors, key enzymes and metabolites. He also touches on Endo vs Phytocannabinoids vs synthetics, cannabinoid receptor agonists/antagonists, entourage effects, genetic variants, endocannabinoid deficiency syndromes, and downregulation/tolerance.

Dr. Morgan explains how the ECS is essential because of its interaction with so many systems in our bodies and why it is important in protection of the human body.

In this video, Dr. Morgan discusses the difference between medicinal cannabis vs recreational use cannabis.

In this video, Dr. Morgan defines and explores psychoactivity vs psychotoxicity.

An introduction to routes of administration.

In this video, Martha Montemayor, CNC, discusses the most common route of administering cannabis by inhaling or smoking. She covers the benefits and disadvantages of this common method of consumption.

In this video, Ms. Montemayor discusses the additional methods of consuming cannabis: oral absorption, edibles / GI absorption, transdermals, and infused bath products. She also covers the form / method onset duration for each method.

In this video, Martha Montemayor discusses cannabinoids and strains and if strains should be recommended to patients. She also discusses the importance of lab results and terpenes in the medical effect of the plant.

In this video, Martha Montemayor recaps the routes of administration, covers starting doses for new cannabis patients and deciphering the proper dose. She also discusses signs of THC overdose and how it is best handled.

In this video, Martha Montemayor discusses the four patient treatment plans: Prophylactic helps prevent problem from starting and building up strength; Daily Support; Acute or Episodic Relief; and Relaxation as stress relief is important to recovery.

An introduction to deciphering lab results and reading labels.

In this video segment, Josh Wurzer discusses the components of lab testing. He provides a breakdown of the Certificate of Analysis (COA), including what to look for on the lab results and which components you should see on cannabis product labels.

In this video segment, Josh Wurzer discusses test results. This includes deciphering results directly from the laboratory, which include the nuances for each product type.

In this video segment, Josh Wurzer discusses lab testing and the active ingredients most important to consumers. These ingredients include cannabinoid and terpene profiles, as well as contaminant results for heavy metals, pesticides, residual solvents, and processing chemicals.

In this video segment, Josh Wurzer discusses interpreting the many aspects of cannabis product labels. This includes typical lab components such as quantity, potency level, input material, and extraction method.

An introduction to medical cannabis research.

In this video segment, Dr. McCue discusses why it is difficult to find good clinical medical cannabis research. He describes how reliable clinical research has been shackled by federal laws and regulations. In turn, nearly all research is done abroad, or published in obscure journals with limited peer review.

In this video segment, Dr. McCue discusses how evidence-based medicine merges scientific findings with clinicians’ best medical judgment based on their experience and what the patient is seeking from their medical care.

In this video segment, Dr. McCue talks about the inconsistent findings of cannabis-based studies, including limitations of randomized control trials in the field, and problems with measurement of dose and type of cannabinoids.

In this video segment, Dr. McCue explores state-of-the-art research in cannabis compounds for treating various medical conditions. He discusses clinical data and plausible mechanisms of action in the treatment of common evidence-based uses of cannabis.

In this video segment, Dr. McCue discusses future developments in the broad field of cannabis research. This includes new, innovative ways to perform cannabis research, and the integration of patients' clinical experiences.

An introduction to pharmacokinetics and pharmacodynamics of cannabis.

In this video segment, Dr. Tagen talks about cannabis PK/PD; the relationship between dose and drug concentrations; and the relationship between drug concentrations and effect. Next, he discusses why PK/PD is complicated as it is used in many conditions with multiple routes of administration.

In this video segment, Dr. Michael Tagen discusses how THC activates our main cannabinoid receptors CB1 and CB2 as a partial agonist. Next, he discusses how the distribution of CB1 explains diverse THC side effects depending on dose titration. Finally, THC pharmacodynamics in pain is discussed.

In this video segment, Dr. Michael Tagen explores CBD pharmacodynamics and how the diversity of the condition it may treat is due to complex pharmacology. Next, the direct and indirect effects of CBD and the CB1 receptor are discussed.

In this video segment, Dr. Michael Tagen talks about CBD and anxiety. He explores anecdotal reports and animal model data that show robust effects in reduced anxiety levels for patient volunteers.

In this video segment, Dr. Michael Tagen explores CBD and its potential for patients with psychosis. CBD is discussed as a promising therapeutic alternative for psychosis, as well as its effectiveness in treating schizophrenia and autism.

In this video segment, Dr. Michael Tagen discusses the anti-inflammatory benefits of CBD, and the emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. The role of the endocannabinoid system and all the ways we can modulate it are also discussed.

In this video segment, Dr. Michael Tagen discusses CBD and pain. This includes CBD's anti-inflammatory and analgesic properties that can help with pain conditions that might otherwise be treated with OTC drugs and opioid medications.

In this video segment, Dr. Michael Tagen talks about the interactions between CBD and THC. This set of drug interactions between components of the cannabis plant is further discussed as having the Entourage Effect. Finally, strong evidence suggests improved THC tolerability and improved efficacy relates to the synergistic activity between CBD and THC.

In this video segment, Dr. Michael Tagen explores cannabinoid pharmacokinetics. The pulmonary, gastrointestinal, and dermal categories of cannabis administration are discussed, as well as dose titration between inhaled methods and oral dosing.

In this video segment, Dr. Michael Tagen talks about factors that affect oral dosing. He describes how PK variability is high with oral dosing, as well as how the categories of metabolism, food affects, and formulation influence THC bioavailability and absorption rates.

In this video segment, Dr. Michael Tagen talks about cannabinoid administration via skin. Transdermal formulations are intended to be absorbed systemically, whereas topical formulations are designed to treat skin conditions. Finally, the role for cannabinoids in a variety of inflammatory skin diseases is discussed.

In this video segment, Dr. Michael Tagen explores terpene pharmacokinetics and pharmacodynamics. The caveats of terpenes are discussed, as well as their unique pharmacology compared to cannabinoids. Finally, the current research we have is largely anecdotal, and more clinical studies are needed to better understand the processing conditions that can affect terpene content.

An introduction to autoimmune diseases, the gut, and CBD.

This video defines autoimmune disease, both the known and unknown types of the disease. It further goes into how to detect and treat the disease.

This video goes over how to develop and treat autoimmune disease, as well as the three factors that impact disease.

This video covers how CBD and THC are used to treat autoimmune disease.

This video discusses how to use cannabis to treat autoimmune disease, as well as how to remove the triggers.

This video covers the personal story regarding a registered nurse who has fibromyalgia and rheumatoid arthritis.

An introduction to cannabis use in psychiatry.

This video discusses the literature surrounding cannabis and its medical benefits. It also reviews all of the mental illnesses that currently impact Americans.

This video covers cannabis as a medication, and its safety.

This video covers addiction treatment and medical marijuana as an option for treating those addictions.

This video discusses the effects of alcohol vs. medical marijuana.

This video discusses how psychiatry views medical marijuana, and the changes in perceptions surrounding its therapeutic effects.

This video discusses the impact that CBD and THC have on improving anxiety issues.

This video covers medical conditions that cause mental disorders, such as depression, anxiety, and sleep disorders.

This video discusses Alzheimer's, and how the use of medical marijuana can be used to lessen the effects of some of the symptoms of this disease.

An introduction to cannabis, pain, and narcotics.

This video discusses the endocannabinoids system and how it interacts with our body.

This video covers how to prevent addiction when using narcotics for medical reasons.

This video discusses how to treat addiction for those suffering from chronic pain who have turned to narcotics. It also discusses how to treat addiction for those who started using narcotics at a young age.

This video covers the future of THCV and all of the helpful benefits that come along with it.

This videos covers how to take a cannabis tincture.

In this video segment, Jack D. McCue, MD FACP AGSF, introduces his course on Medical Cannabis and Neurodegenerative Disorders.

In this video segment, Jack D. McCue covers the effects of cannabinoids in neurodegenerative disorders. He talks about how there are three major symptoms for people to gravitate to medical cannabis: behavioral symptoms, constitutional symptoms, global benefits. Neuroprotection is also a possible disease modification by cannabinoids in neurodegenerative disorders. The endocannabinoid system may be our most important neural and immune regulator system – a modulator system that prevents other basic processes from getting out of control through on-demand negative feedback.

In this video segment, Jack McCue talks about medical cannabis in regard to Alzheimer's Disease. Alzheimer's Disease has multifactorial risk factors, including genetics (primarily early-onset), environmental factors, trauma, and aging. In Alzheimer's research with animal models, studies have found: Cannabinoids are Anti-inflammatory & Reduce Mitochondrial Dysfunction and Oxidative Stress. There is also the Effect of Cannabinoids on Aβ & p-tau:
Biologic Plausibility.

In this video segment, Jack McCue breaks down the human studies of cannabis in Alzheimer's Disease. Some of the studies include autopsy studies that showed increased activity of the endocannabinoid system in AD patient brains at the sites responsible for memory loss and increased CB2 receptors in microglia at plaques.

In this video segment, Jack D. McCue covers how cannabis plays a role with multiple sclerosis. MS is pathologically defined as multiple scars or “plaques” in the brain and/or spinal cord. It was clinically recognized in the 14th century, but not codified into reliable clinical and pathologic criteria until 1868 when described by the prominent neurologist Charcot. Its criteria was updated in 2010 to incorporate MRI abnormalities.

In this video segment, Jack D. McCue breaks down the clinical studies of cannabinoids in multiple sclerosis.

In this video segment, Jack D. McCue answers if cannabis is neuroprotective in multiple sclerosis.

In this video segment, Jack D. McCue will talk about other neurodegenerative disorders where cannabis might be beneficial. The main two areas of concentration are ALS & Parkinson's Disease.

In this video segment, Amy Silverman gives a nurse's perspective regarding cannabis for elders. Amy became a cannabis nurse because it had helped her. After fighting an autoimmune disease, she used CBD to transform her life. She has seen how cannabis works, and that it can be a gateway to wellness.

In this video segment, Amy Silverman tells a patient's story of using medical cannabis. Amy talks about an overly obese man who was in pain but stayed the course, lost weight, and is no longer a diabetic. Cannabis helps patients get their pain or ailments settled, which is the starting point. Then they can move forward with their plan of attack.

In this video segment, Amy Silverman talks about clinical experiences of cannabis as a nurse. It is important to know about the obstacles of using medical cannabis versus the traditional health care system, which includes long-term help and hospitals. Many people dealing with pain typically rely on basic medicine and sometimes opioids. Amy helps patients see the benefits of using medical cannabis for their health issues.

An introduction to cannabis use among elderly patients and age-related diseases.

In this video segment, Dr. Cohen expands upon how CBD can be used by elderly patients to treat neurodegenerative diseases. This video also gives an overview of how CBD works within the body and how it acts as a non-psychoactive alternative.

This video discusses the benefits of combining THC and CBD while also providing a scientific explanation of how they effect the body. Elderly patients can effectively use THC and CBD to treat chronic pain, anxiety, insomnia, and much more.

This video shows that the benefits of CBD will increase when it is used in tandem with other cannabinoids and terpenes. When combined, they have been shown to treat anxiety, insomnia, and other ailments, while also maintaining anti-cancer and anti-inflammatory properties.

This video discusses how different delivery methods can impact a cannabis user's experience. In addition, this video discusses the pros and cons of several delivery methods including: topicals, smoking, concentrates, intra-oral, ingestible, and transdermal.

This video discusses two main age-related diseases, osteoarthritis and neurodegenerative disease, which are both related to inflammation. This video also discusses sources of inflammation, how it manifests in the body, and how it can be treated with CBD.

This video discusses neurodegenerative diseases that are common among elderly patients and include ailments such as Parkinson’s, multiple sclerosis, ALS, dementia, and Alzheimer’s. In addition, this video discusses why CBD and THC are promising potential treatments for neurodegenerative disorders.

This video discusses several ways medical professionals can manage their patients' experiences with age-related diseases and cannabis usage. This includes identifying important issues such as their history of cannabis use, current methods of use, frequency, timing, dosage, and tolerance.

This video is an introduction to the course on cannabis and cancer.

This video discusses how cannabis products can be used to prevent the formation of cancer cells. While future studies will need to be performed for confirmation, cannabis products have been shown to help prevent ailments related to coronary circulation, cerebral circulation, stroke, and heart attack.

This video discusses how cannabis products can lessen the side effects related to cancer treatments. The video also highlights several developments in this field, including how CBD has been found to prevent neuropathy from neurotoxic chemotherapy.

This video discusses multiple studies that highlight how cancer can be treated and managed with the help of cannabis. There is even evidence that suggests ancient civilizations used cannabis as a cancer treatment.

This video discusses common questions regarding cannabis dosing and cancer treatments. In addition, it discusses current studies that are examining which dosing levels are the most effective for cancer patients.

This video discusses possible therapies that can benefit from cannabis. The video also discusses scholarly studies regarding bioavailability, excipients, and absorption rates.

This video highlights the dynamic relationship that exists between CBD, anandamide, and cancer. It also discusses how these molecules influence chemical changes within the body.

This video discusses the future that awaits cannabis and cancer treatments. It also discusses the need for double-blind studies, clinical trials, observational studies, and placebo-controlled studies.

An introduction to cannabis regulations and legal matters for medical professionals.

This video provides context on federal regulations and laws regarding cannabis. In this course, learners will gain a better understanding of the States Act, the 2014 Farm Bill, the 2018 Farm Bill, and much more.

This video discusses the complicated legal landscape of cannabis regulations at the state level. Many states have a unique licensing structure and have different requirements for patient-facing entities. While cannabis is entirely illegal in some states, there are an increasing number of states that are permitting adult use.

This video discusses the international landscape of cannabis regulations and laws. In recent years, there have been many developments in regions such as Europe, Latin America, Asia, and North America. Within this course, learners will examine these developments, international treaties, the World Health Organization, and much more.

This video discusses liability risks that medical professionals should be aware of before recommending THC-based cannabis to patients. This video provides an overview of THC, how it will impact the body, potential drug interactions, state guidelines, informed consent, and much more.

This video details legal issues that cannabis professionals must be aware of before selling retail products. It discusses the roles of retail staff, budtenders, and delivery drivers who must have an understanding of these legal matters when performing their jobs. In addition, this video reviews standards of care, common patient complaints, training programs, product education, and more.

This video discusses the legal issues that patients should understand before interacting with cannabis products. This video also examines access to medical cannabis, shipping, traveling, firearm eligibility, drug testing, state medical programs, and much more.